Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TOPIRAMATE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for TOPIRAMATE EXTENDED-RELEASE CAPSULES. TOPIRAMATE extended-release capsules, for oral use Initial U.S. Approval: 1996
Medication labelWhy this: Advisory · dailymed-prescription
Topiramate extended-release capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. Topiramate extended-release capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older. Topiramate extended-release capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older.
- generic_name
- topiramate
- product_names
- topiramate
- ndc
- 68462-372, 68462-373, 68462-374, 68462-370, 68462-371, 68462-372-30, 68462-372-90, 68462-372-05, 68462-373-30, 68462-373-90, 68462-373-05, 68462-374-30, 68462-374-90, 68462-374-05, 68462-370-30, 68462-370-90, 68462-370-05, 68462-371-30, 68462-371-90, 68462-371-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en